[Benign prostatic syndrome (BPS). Ablative treatments].
Today, the surgical treatment of the benign prostatic syndrome (BPS) often follows a course of drug treatment. Besides conventional transurethral resection of the prostate (TURP), which has represented the standard therapeutic option for decades, and its in part significant modifications ("vaporizing resection"; bipolar resection), much of the interest has shifted to alternative instrumental procedures like transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA) or several laser techniques. By reviewing the current literature, preferably from randomized controlled trials, these different procedures are critically assessed. Moreover, the present role of open prostatectomy is discussed.
Reich
O
O
Urologische Klinik und Poliklinik, Klinikum Grosshadern, Ludwig-Maximilians-Universität, 81377 , München, oreich@med.uni-muenchen.de
Seitz
M
M
Gratzke
C
C
Schlenker
B
B
Bachmann
A
A
Stief
C
C
D004724:Endoscopy; D004867:Equipment Design; D007172:Erectile Dysfunction / Q000209:etiology; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000209:etiology*; D019106:Postoperative Hemorrhage / Q000209:etiology; D017410:Practice Guidelines as Topic; D011467:Prostate / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000473:pathology / Q000601:surgery*; D016032:Randomized Controlled Trials as Topic; D020728:Transurethral Resection of Prostate / Q000295:instrumentation*; D016055:Urinary Retention / Q000209:etiology; D014563:Urodynamics / Q000502:physiology